These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6172215)

  • 1. Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.
    Alberts DS; Chen HS; Salmon SE; Surwit EA; Young L; Moon TE; Meyskens FL
    Cancer Chemother Pharmacol; 1981; 6(3):279-85. PubMed ID: 6172215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiagent chemotherapy in relapsing ovarian cancer.
    Surwit EA; Alberts DS; Crisp W; Jackson RA; Grozea PN; Leigh S
    Am J Obstet Gynecol; 1983 Jul; 146(6):613-6. PubMed ID: 6191568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy?
    Welander CE; Homesley HD; Jobson VW
    Am J Obstet Gynecol; 1983 Sep; 147(2):188-95. PubMed ID: 6614100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.
    Alberts DS; Salmon SE; Chen HS; Moon TE; Young L; Surwit EA
    Cancer Chemother Pharmacol; 1981; 6(3):253-64. PubMed ID: 7318146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin.
    Tsuruo T; Hamilton TC; Louie KG; Behrens BC; Young RC; Ozols RF
    Jpn J Cancer Res; 1986 Sep; 77(9):941-5. PubMed ID: 2429947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug testing using a soft agar stem cell assay on patient and xenograft tumor material.
    Hanson J; Coombs A; Moore JL
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1697-701. PubMed ID: 6207157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
    Takamizawa H; Sekiya S; Iwasawa H; Ishige H; Tokita H; Tanaka N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy testing for human ovarian cancer using in vitro colony assay].
    Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1593-8. PubMed ID: 2411225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.
    Alberts DS; Samon SE; Chen HS; Surwit EA; Soehnlen B; Young L; Moon TE
    Lancet; 1980 Aug; 2(8190):340-2. PubMed ID: 6105478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pretherapeutic chemosensitivity testing of ovarian cancer and possibilities for its clinical use].
    Hernádi Z; Pásti G; Lampé L; Juhász B
    Zentralbl Gynakol; 1985; 107(17):1065-71. PubMed ID: 4060913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. I. Results of a prospective randomized phase III-study with 71 patients with disseminated disease (stage IV) (author's transl)].
    Scheulen ME; Higi M; Schilcher RB; Meier CR; Seeber S; Schmidt CG
    Klin Wochenschr; 1980 Aug; 58(16):811-21. PubMed ID: 6161273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
    Salmon SE; Hamburger AW; Soehnlen B; Durie BG; Alberts DS; Moon TE
    N Engl J Med; 1978 Jun; 298(24):1321-7. PubMed ID: 77475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy sensitivity of gynecologic malignancies determined by the human tumor stem cell assay (HTSCA)].
    Obi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):792-8. PubMed ID: 3598274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture.
    Epstein LB; Marcus SG
    Cancer Chemother Pharmacol; 1981; 6(3):273-7. PubMed ID: 6172214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the colony formation test in ovarian carcinoma].
    Runge HM; Bücke W; Neumann HA
    Onkologie; 1984 May; 7 Suppl 2():66-73. PubMed ID: 6235468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemosensitivity testing for human ovarian cancer on in vitro colony assay].
    Inoue K
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1146-51. PubMed ID: 6471421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.
    Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
    Cancer Treat Rep; 1981; 65(1-2):1-12. PubMed ID: 7226159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer.
    Edwards CL; Herson J; Gershenson DM; Copeland LJ; Wharton JT
    Gynecol Oncol; 1983 Apr; 15(2):261-77. PubMed ID: 6403413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.